Mr Kam Balaggan
Mr Kam Balaggan-is a Consultant Ophthalmologist Surgeon in Staffordshire
Based At
NHS base
Wolverhampton and Midland Counties Eye Infirmary
GMC Number
4415651
Clinic Timetable
Clinical interests
Mr Balaggan specialises in state of-the-art modern micro-incision sutureless vitrectomy surgery and micro-incision cataract surgery. He provides completely comprehensive surgical and laser treatment of: Complex and routine retinal detachments and tears, Floaters, Macular holes, Epiretinal membranes, Vitreomacular traction, Diabetic retinal detachments.
Professional Memberships
BSc MBBS FRCOphth PhD
Mr Balaggan has an outstanding track record in research and teaching. He spent 4 years full-time researching at University College London developing cutting-edge novel retinal gene therapies for macular degeneration and inherited retinal disorders. He was awarded a PhD for this work, and has authored 30 peer-reviewed publications, including in the prestigious journals Nature Medicine, and New England Journal of Medicine. He has given numerous lectures nationally and internationally relating to his research, and also peer-reviews for 6 scientific journals. Mr Balaggan has been awarded 6 local/ national and international prizes including the prestigious Moorfields Eye Hospital Research Medal (2007), Royal College of Ophthalmologists Foulds Trophy (2011), Best Paper Presentation American Academy of Ophthalmology (2012), Best Surgical Video Prize Euretina (2007). 1st Runner up Allergan Research Prize (2009), and 1st Runner up Best Young Scientist British Society of Gene Therapy (2006). Mr Balaggan was a key co-investigator in the world's first gene therapy trial for an inherited retinopathy, and in the first randomised clinical trial of bevacizumab for corneal neovascularisation. He co-designed, and is the Principal Investigator for a trial evaluating a novel radiotherapy device for the treatment of macular degeneration. Mr Balaggan was also awarded the Best NHS Tutor Award(2012) by Bart's and the London Medical School, and the Moorfields Educational Achievement Award(2013) in recognition of his enthusiasm for and skills in teaching trainee doctors and ophthalmologists.
Academic Background
Mr Balaggan is unique in being one of exceptionally few surgeons that have completed not just 2 years of prestigious high-volume Fellowships in Vitreoretinal Surgery, but also 2 years of sub-specialist Fellowship training in Medical Retina, all at the internationally-renowned Moorfields Eye Hospital, London. This was in addition to his general training, which was also predominantly based at this Centre of Excellence and one of the world's top Eye Hospitals. He also obtained a PhD from University College London (ranked in the top 5 universities globally), and has been awarded numerous prizes recognising his contribution to advancing frontiers in ophthalmology and for his teaching excellence (see research). He is considered an expert in retinal medicine and surgery, and has often been invited to lecture both nationally and internationally, teaching other retinal specialists.
NHS base
Wolverhampton and Midland Counties Eye Infirmary
GMC Number
4415651
Clinic Timetable
Clinical interests
Mr Balaggan specialises in state of-the-art modern micro-incision sutureless vitrectomy surgery and micro-incision cataract surgery. He provides completely comprehensive surgical and laser treatment of: Complex and routine retinal detachments and tears, Floaters, Macular holes, Epiretinal membranes, Vitreomacular traction, Diabetic retinal detachments.
Professional Memberships
BSc MBBS FRCOphth PhD
Mr Balaggan has an outstanding track record in research and teaching. He spent 4 years full-time researching at University College London developing cutting-edge novel retinal gene therapies for macular degeneration and inherited retinal disorders. He was awarded a PhD for this work, and has authored 30 peer-reviewed publications, including in the prestigious journals Nature Medicine, and New England Journal of Medicine. He has given numerous lectures nationally and internationally relating to his research, and also peer-reviews for 6 scientific journals. Mr Balaggan has been awarded 6 local/ national and international prizes including the prestigious Moorfields Eye Hospital Research Medal (2007), Royal College of Ophthalmologists Foulds Trophy (2011), Best Paper Presentation American Academy of Ophthalmology (2012), Best Surgical Video Prize Euretina (2007). 1st Runner up Allergan Research Prize (2009), and 1st Runner up Best Young Scientist British Society of Gene Therapy (2006). Mr Balaggan was a key co-investigator in the world's first gene therapy trial for an inherited retinopathy, and in the first randomised clinical trial of bevacizumab for corneal neovascularisation. He co-designed, and is the Principal Investigator for a trial evaluating a novel radiotherapy device for the treatment of macular degeneration. Mr Balaggan was also awarded the Best NHS Tutor Award(2012) by Bart's and the London Medical School, and the Moorfields Educational Achievement Award(2013) in recognition of his enthusiasm for and skills in teaching trainee doctors and ophthalmologists.
Academic Background
Mr Balaggan is unique in being one of exceptionally few surgeons that have completed not just 2 years of prestigious high-volume Fellowships in Vitreoretinal Surgery, but also 2 years of sub-specialist Fellowship training in Medical Retina, all at the internationally-renowned Moorfields Eye Hospital, London. This was in addition to his general training, which was also predominantly based at this Centre of Excellence and one of the world's top Eye Hospitals. He also obtained a PhD from University College London (ranked in the top 5 universities globally), and has been awarded numerous prizes recognising his contribution to advancing frontiers in ophthalmology and for his teaching excellence (see research). He is considered an expert in retinal medicine and surgery, and has often been invited to lecture both nationally and internationally, teaching other retinal specialists.
